论文部分内容阅读
Spinal cord injury (SCI) is a detrimental condition, in China, up to 10 000 people each year are affected by this condition.Anti-NogoA (α-NgA) antibody and chondroitinase ABC (ChABC) enzyme are two promising treatments that promote functional recovery after SCI.